BrightSpring Health announced that Dr. Steve Miller was appointed as a Class II member of the Board of Directors. Dr. Miller will also serve as a member of the Board’s Audit Committee and as the chair of the Board’s Quality & Compliance and Governance Committee. Dr. Miller served as the Chief Clinical Officer for Cigna from 2018 to 2022, transitioning to an expert advisor role in 2022 for Cigna’s efforts across clinical policy, quality, and performance programs.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- Walgreens liquidity concerns to persist, says Barclays
- KKR to purchase 11.62M shares of BrightSpring Health from Walgreens
- North Central Florida Hospice completes asset sale to BrightSpring Health
- BrightSpring Health completes acquisition of Haven Hospice
- BrightSpring inspections see ‘serious regulatory violations,’ Capitol Forum says